World's Best Scientists 2026 revealed!
Yoshiyuki Ohsugi

Yoshiyuki Ohsugi

D-Index & Metrics

Immunology

D-Index
51
Citations
11903
World Ranking
4127
National Ranking
92

Overview

Yoshiyuki Ohsugi is a researcher affiliated with Roche (Switzerland) located in Switzerland. Their work is situated within the pharmaceutical industry, contributing to research and development efforts at this prominent company.

While specific details about their publications such as recent papers, frequent co-authors, and main fields of study are not available, the professional association with Roche indicates involvement in applied biomedical sciences or related areas typical for a pharmaceutical environment. The absence of listed co-authors or frequent publication venues suggests a possible focus on internal research or proprietary projects rather than frequent publication in external academic journals.

No records of book publications or awards have been noted for Yoshiyuki Ohsugi. This could reflect a primary emphasis on research and development activities rather than broader academic dissemination or recognition through formal awards.

The profile does not include specific information about research themes or subfields of study, and there are no available data on main topics of work. This implies that publicly accessible information about the precise scientific interests and contributions of Yoshiyuki Ohsugi is limited or not documented in conventional research databases.

Overall, Yoshiyuki Ohsugi represents a scientist working within the context of a global pharmaceutical company, potentially contributing to product development, clinical research, or related scientific work aligned with Roche's operational focus. Their career illustrates an industry-based pathway consistent with researchers embedded in corporate environments where the dissemination of research may be directed toward internal goals or proprietary innovation.

Best Publications

  • Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

    T Tamura;N Udagawa;N Takahashi;C Miyaura

  • Reshaping a Human Antibody to Inhibit the Interleukin 6-dependent Tumor Cell Growth

    Koh Sato;Masayuki Tsuchiya;Jośe Saldanha;Yasuo Koishihara

  • Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130

    Masashi Narazaki;Kiyoshi Yasukawa;Takashi Saito;Yoshiyuki Ohsugi

  • IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.

    Satoshi Serada;Minoru Fujimoto;Masahiko Mihara;Nobuo Koike

  • Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.

    Masahiko Mihara;Keiko Kasutani;Makoto Okazaki;Akito Nakamura

  • Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis

    Nobuhiro Takagi;Masahiko Mihara;Yoichiro Moriya;Norihiro Nishimoto

  • Blockade of Interleukin-6 Receptor Suppresses Reactive Astrogliosis and Ameliorates Functional Recovery in Experimental Spinal Cord Injury

    Seiji Okada;M. Nakamura;Y. Mikami;T. Shimazaki

  • Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.

    Minoru Fujimoto;Satoshi Serada;Masahiko Mihara;Yasushi Uchiyama

  • INTERLEUKIN-6 (IL-6) INDUCES THE PROLIFERATION OF SYNOVIAL FIBROBLASTIC CELLS IN THE PRESENCE OF SOLUBLE IL-6 RECEPTOR

    M. Mihara;Y. Moriya;T. Kishimoto;Y. Ohsugi

  • Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis

    Takeru Yoshimura;Koh Hei Sonoda;Nobuyuki Ohguro;Yoshiyuki Ohsugi

  • Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons.

    Toru Yamashita;Kazunobu Sawamoto;Shigeaki Suzuki;Norihiro Suzuki

  • Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component

    Tadamitsu Kishimoto;Masahiko Mihara;Yoichiro Moriya;Yoshiyuki Ohsugi

  • ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1

    Yuichi Hirata;Naoki Kimura;Koh Sato;Yoshiyuki Ohsugi

  • Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6

    Chisato Miyaura;Kenichiro Kusano;Toshihide Masuzawa;Osamu Chaki

  • Purification and characterization of soluble human IL-6 receptor expressed in CHO cells.

    Kiyoshi Yasukawa;Takashi Saito;Takeshi Fukunaga;Yasuo Sekimori

  • Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.

    Youichi Mizutani;Benjamin Bonavida;Yasuo Koishihara;Ken-ichi Akamatsu

  • Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.

    Hitoshi Tai;Chisato Miyaura;Carol C. Pilbeam;Tatsuya Tamura;Tatsuya Tamura

  • Muscle Undergoes Atrophy in Association with Increase of Lysosomal Cathepsin Activity in Interleukin-6 Transgenic Mouse

    T. Tsujinaka;C. Ebisui;J. Fujita;M. Kishibuchi

  • Anti‐interleukin‐6 receptor antibody prevents muscle atrophy in colon‐26 adenocarcinoma‐bearing mice with modulation of lysosomal and ATP‐ubiquitin‐dependent proteolytic pathways

    Junya Fujita;Toshimasa Tsujinaka;Masahiko Jano;Chikara Ebisui

  • Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization

    Kanako Izumi-Nagai;Norihiro Nagai;Yoko Ozawa;Masahiko Mihara

Frequent Co-Authors

Tadamitsu Kishimoto
Tadamitsu Kishimoto Osaka University
Tadanori Mayumi
Tadanori Mayumi Kobe Gakuin University
Shinsaku Nakagawa
Shinsaku Nakagawa Osaka University
Masafumi Takahashi
Masafumi Takahashi Jichi Medical University
Naoki Okada
Naoki Okada Osaka University
M. Eric Gershwin
M. Eric Gershwin University of California, Davis
Kiyoshi Yasukawa
Kiyoshi Yasukawa Kyoto University
Hideyuki Okano
Hideyuki Okano Keio University
Tetsuji Naka
Tetsuji Naka Kōchi University
Minoru Fujimoto
Minoru Fujimoto Kōchi University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various healthcare and nursing fields that offer specialized online degrees. For those interested in advanced practice roles, exploring which nurse practitioner program is easiest can help streamline your educational journey without compromising quality. This consideration is crucial for balancing rigorous coursework with clinical experience.

Specifically, programs like the top pmhnp programs offer valuable training for those drawn to psychiatric mental health, an area closely linked to immunological research and patient care. These programs often boast impressive clinical placement rates, ensuring hands-on experience that is essential for licensure and practice.

Cost is another major factor for students exploring online options. Identifying the cheapest psych np programs can alleviate financial barriers while maintaining accreditation and educational standards. Affordable programs allow students to focus more on mastering their specialty areas rather than worrying about debt.

Lastly, understanding future earning potential is important when choosing a career path. Insights into how much does a dnp make, especially by state, can guide decisions on which programs to pursue and where to practice post-graduation. This financial perspective helps align one's passion for immunology with sustainable career outcomes.

Best Scientists Citing Yoshiyuki Ohsugi

Trending Scientists

Recently Published Articles